Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15-Reference-Cited by-同舟云学术

Treatment-damaged hepatocellular carcinoma promotes activities of hepatic stellate cells and fibrosis through GDF15

Published:2018-09 Issue:2 Volume:370 Page:468-477
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Dong Gang,Ma Min,Lin Xiahui,Liu Huahua,Gao Dongmei,Cui Jiefeng,Ren Zhenggang,Chen Rongxin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology

Reference29 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;LANCET,2002

3. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology,2002

4. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

5. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma;Lu;Hepatogastroenterology,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth differentiation factor 15: Emerging role in liver diseases;Cytokine;2024-10

2. Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target;Hepatology Communications;2024-07

3. GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications;Journal of Hepatocellular Carcinoma;2024-06

4. Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure;Life Sciences;2024-04

5. Dibutyl phthalate induces liver fibrosis via p38MAPK/NF-κB/NLRP3-mediated pyroptosis;Science of The Total Environment;2023-11